Iterative Health vs TeraRecon
TeraRecon is advanced visualization plus a platform that hosts other vendors' algorithms. Its own algorithms segment CT and MR: Cardiac.Chambers.MR (November 2024), Aorta.CT (January 2025) and Cardiovascular.Calcification.CT (October 2025), the last for GE or Siemens CT only. A cardiac imaging service that wants several vendors' results in one viewer buys it. The AI Framework page shows Infervision and Optellum among its partner logos.
On ownership, TeraRecon's About timeline lists SymphonyAI in 2020 and a ConcertAI integration in 2021, and its newsroom now writes ConcertAI's TeraRecon. Iterative Health appears as Iterative Scopes, Inc. on FDA files through 2024 and headlines a $77 million Series C aimed at clinical research.
SKOUT analyzes colonoscopy video, a decision for an endoscopy suite. Its sponsor-run randomized trial at five centers found 0.83 adenomas per colonoscopy without the device and 1.05 with it. A CT or MR service evaluating a viewer has nothing in that trial to weigh.
Radiology · Reviewed November 2, 2026
Iterative Health
by Iterative Health · founded 2017
Real-time AI polyp detection for colonoscopy with the FDA-cleared SKOUT system, for endoscopists and endoscopy centers.
TeraRecon
by ConcertAI · founded 1997
Advanced CT and MR visualization with cardiac, aorta and neuro AI, plus a vendor-agnostic platform to run third-party AI.
When to pick each one
Iterative Health
- Endoscopy centers adding colonoscopy CADe
- 0.83 to 1.05 adenomas per colonoscopy in the trial
TeraRecon
- Runs several vendors' AI in one platform
- Cardiac MR, aorta and neuro algorithms
Score
Each row shows points earned of points available under the published rubric.
Iterative Health
42of 100
TeraRecon
42of 100
| Dimension | Iterative Health | TeraRecon | Difference |
|---|---|---|---|
| FDA clearance | 18 / 18 | 18 / 18 | 0 |
| HIPAA / SOC2 / BAA | 0 / 10 | 0 / 10 | 0 |
| EHR integrations (count) | 0 / 4.2 | 0 / 4.2 | 0 |
| Top-3 EHR coverage (Epic / Oracle / Athena) | 0 / 2.4 | 0 / 2.4 | 0 |
| Peer-reviewed papers | 0 / 18.2 | 0 / 18.2 | 0 |
| RCT / meta-analysis / systematic review | 0 / 7.8 | 0 / 7.8 | 0 |
| Funding & adoption signal | 8.4 / 12 | 8.4 / 12 | 0 |
| Pricing transparency | 2.5 / 5 | 2.5 / 5 | 0 |
| Years in market | 6 / 6 | 6 / 6 | 0 |
Scroll horizontally to see every column.
Pricing
Iterative Health
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. Demo request only. |
TeraRecon
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. |
Evidence
Iterative Health
FDA decisions
K253664 (opens in new tab)510(k)2025-12-22
SKOUT system
K251126 (opens in new tab)510(k)2025-05-09
SKOUT system
K241508 (opens in new tab)510(k)2024-07-03
SKOUT system
K240781 (opens in new tab)510(k)2024-04-19
SKOUT system
K230658 (opens in new tab)510(k)2023-04-07
SKOUT system
Show 1 more
K213686 (opens in new tab)510(k)2022-08-12
SKOUT Software
TeraRecon
FDA decisions
K250288 (opens in new tab)510(k)2025-10-23
TeraRecon Cardiovascular.Calcification.CT
K243158 (opens in new tab)510(k)2025-01-23
TeraRecon Aorta.CT (1.1.0)
K241312 (opens in new tab)510(k)2024-11-05
TeraRecon Cardiac.Chambers.MR (1.0.0)
K220349 (opens in new tab)510(k)2022-08-12
TeraRecon Neuro
K200750 (opens in new tab)510(k)2020-11-06
Neuro.AI Algorithm
Show 2 more
K191585 (opens in new tab)510(k)2019-07-12
iNtuition-Structural Heart Module
K180916 (opens in new tab)510(k)2018-09-24
iNtuition-T1 Mapping and T2/T2* Mapping
Compliance and integrations
Documented from each vendor’s own pages.
| Spec | Iterative Health | TeraRecon |
|---|---|---|
| Free tier | ||
| HIPAA | ||
| SOC 2 Type II | ||
| EHR integrations | Not specified | Not specified |
| Founded | 2017 | 1997 |
| HQ | US | US |
Scroll horizontally to see both columns.
Common questions
Open the full radiology comparison
Acute-care triage, mammography screening, CCTA plaque analysis, mobile MRI. 30+ FDA-cleared platforms across stroke, oncology, cardiac. Enterprise sales only — we compared what's deployed where.